Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

Clinical trial NCT04905693 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT04905693
Sponsor: United Therapeutics
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Progressive Pulmonary Fibrosis

Start date: 2022-09-06
Primary completion: 2029-12-01
Enrollment: 1850

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.